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Abstract 
 
This paper evaluates the individual and combined effects of exporting and outward foreign direct investments (OFDI) 
RQ ILUPV· WHFKQRORJ\ LQYHVWPHQWVat home using firm-level data from the pharmaceutical industry in India. The 
analysis accounts for unobserved firm heterogeneity and the endogeneity of the choice of foreign market participation, 
and shows that exporting has been an important channel through which Indian multinational expansion has 
encouraged greater domestic technological activity. However, all else constant, higher levels of OFDI have rather acted 
as substitutes for such technological efforts. 
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1. Introduction 
 
During the past three decades policy makers from a number of developing countries have 
undertaken outward-oriented economic reforms with a view to stimulating the acquisition of 
global capabilities and promoting greater domestic economic activity. The liberalization of trade 
and foreign direct investment regimens have been two important features of such reforms, which 
have resulted in firms from developing countries rapidly expanding their presence in international 
trade and foreign direct investment. However, the extent to which the deliberate outward 
orientation of such firms is related to greater domestic economic activity is still a sparse area of 
research.  In particular, whether firms' international activities in the form of exports and outward 
foreign direct investments (OFDI) affect their technological effort at home remains an important 
open question. 
 
 From a theoretical perspective, recent work in international economics has emphasised 
that improved access to foreign markets due to trade liberalization encourages firms to undertake 
complementary investments in technology adoption and innovation. This connection between 
exporting and technology investments has been modelled and tested empirically in a number of 
different contexts.1  For examSOH %XVWRV·  SURYLGHV HPSLULFDO HYLGHQFH IURP $UJHQWLQD
VKRZLQJ WKDW ILUPV LQ LQGXVWULHV IDFLQJ UHGXFWLRQV LQ %UD]LO·V LPSRUWV WDULIIV DV PDQGDWHG E\
MERCOSUR, increased their investment in technology faster, and exporters upgraded technology 
more rapidly than other firms in the same industry.  Lileeva and Trefler (2010) show that Canadian 
plants that were induced to start exporting, or export more, due to the elimination of U.S. tariffs 
displayed higher rates of technology adoption and innovation.  Constantini and Melitz (2008) show 
how anticipation of trade liberalisation leads firms to innovate in preparation for future 
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participation in export markets, and Atkeson and Burstein (2010) show that a reduction in marginal 
trade costs induces exporting firms to spend more on process innovation than non-exporting firms, 
amplifying the superiority of exporting firms over time.2  
 
 While the above models have focused on the technological effects of improved access to 
foreign markets in the context of liberalization of trade regimes, the technological effects resulting 
from the increased access to foreign markets due to outward FDI liberalization has been absent 
from existing theoretical work in international economics. This issue is particularly relevant in the 
context of developing countries where capital controls have been relaxed in recent years, allowing 
an increasing number of firms to rapidly expand their international operations. However, as yet, 
little effort has been devoted to investigating WKHHIIHFWRIVXFKLQYHVWPHQWVRQILUPV·WHFKQRORJLFDO
performance at home. The international business literature, on the other hand, has focused 
primarily on understanding the characteristics and motivations of developing countries 
multinationals to invest abroad, but little is known about the consequences of such investments 
for the investing firms in their home countries. 3 
 
 Understanding the role of outward FDI for technological improvements in the home 
country is central as there is a considerable concern as to whether the activities of multinational 
enterprises affect the home economies; an issue that is particularly relevant in the context of 
developing countries with scarce capital. On one hand, flows of outward foreign direct investment 
generate fears that such investments come at the cost of reducing economic activity at home. In 
contrast, an alternative perspective suggests that greater outward foreign direct investment could 
enrich home activities by improving the competitiveness of the parent investing firms (Desai, et. 
al., 2005).  
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 The limited empirical literature on the technological implications of overseas investments 
by multinational firms has provided mixed results.  In the context of developing countries, Chuang 
and Lin (1999) find that the overseas investments of Taiwanese manufacturing firms substitute 
their R&D investments at home, whereas Lin and Yen (2005) find complementary effects in the 
Taiwanese electronic industry.  Chen and Yang (2013), on the other hand, show that the 
relationship between outward FDI and domestic R&D is undetermined because overseas 
investments induce complementary as well as substitutive effects.  In the case of India, Pradhan 
and Singh (2009) find that outward FDI by automotive firms exerts a positive impact on the R&D 
intensity of the investing firm.  Those mixed results reveal that the impact of OFDI is likely to 
differ depending on many factors, including the context and the motivations behind such 
investments. Anecdotal evidence and numerous case studies performed on developing country 
multinationals show that those firms are not an homogeneous group. Rather, they differ in a 
number of dimensions, such as their country of origin, the industry in which they operate, and 
their competitive advantage, amongst other aspects (Ramamurti, 2009). Hence, any attempt to 
evaluate the effects of outward FDI on firms' performance should take into account those 
specificities. 
 
 Overall, the sparse empirical literature examining the home-country technological effects 
of the process of globalization of emerging market firms have mainly focused on the individual 
effects of exporting and/or investing abroad. Yet, the complementary technological impact of 
these two activities remains unexplored in the literature. This study investigates empirically the 
individual effects of exporting and investing abroad, as well as their complementary impact on the 
rate of technology investment at home. Examining the individual and complementary effects of 
these two forms of foreign market participation is central to better understanding the channels 
through which foreign activities of emerging market firms shape their technological capabilities at 
home. From a theoretical perspective, this paper aims to contribute to future theoretical work in 
5 
 
international economics by exploring the relevance of a firm's multinational (OFDI) status for the 
technology-exporting link, as well as the direct link between overseas and technological 
investments. The international economics literature tends to regard exporting and investing abroad 
as substitute modes of foreign market participation, yet empirical data show that in many contexts 
firms engage in both activities simultaneously. Hence, the interplay between exporting, investing 
abroad and investing in technology is still an open area for future theoretical and empirical research.     
 Apart from considering the complementary effects of exporting and investing abroad on 
firms' domestic technological efforts, this paper extends previous works by considering a broader 
measure of technology investment that includes not only expenditures on in-house R&D, but also 
expenditures on computers and software, royalty fees, and the imports of capital goods. Also, 
unlike most theoretical models that express technology investment as a binary choice for the sake 
of mathematical tractability, this paper employs continuous measures of technology investment 
which correspond more closely to the notion of technology upgrading. Moreover, this paper 
accounts for firm unobserved heterogeneity and the potential endogeneity of the choice of foreign 
market participation, an issue that has been largely neglected in previous empirical studies analysing 
the effects of OFDI on firms' technological efforts.  
 The policy relevance of this work stems from the fact that Indian policy makers have been 
active in promoting international agreements and liberalising trade and FDI regimes in order to 
encourage technology acquisition by indigenous companies, especially from 2000 onwards.  While 
these efforts have produced remarkable results in terms of export and multinational expansion, 
the cost-effectiveness of such policies in generating greater domestic economic activity remains 
RSHQ WR TXHVWLRQ ,QGLD·V UDSLG HFRQRPLF JURZWK DQG VXFFHVVIXO LQWHJUDWLon with the global 
economy makes it an excellent case study for this topic. As many developing countries are 
becoming active global players, there is a growing interest from researchers and policy makers in 
understanding the strategic responses of firms from these countries as they adjust to trade and 
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FDI liberalization. The analysis covers the years from 1999 to 2007, a period of on-going 
globalization of Indian firms, in contrast to studies based on developed countries where the 
process of internationalisation is not new. 
 
 This study focuses on the pharmaceutical industry in India and is based on the Prowess 
database compiled by the Centre for Monitoring the Indian Economy. The Indian pharmaceutical 
industry is an ideal case to study the relationship between exporting, OFDI and technology 
investments. During the period 1999²2007, exports earnings by Indian pharmaceutical firms was 
a staggering US$14.3 billion, accounting for 2.4% of India's total exports. 4  Parallel to this 
development, and taking advantage of the investment liberalisation policy of the government, 
Indian pharmaceutical firms have been also busy in overseas markets having invested US$1.3 
billion in transnational acquisitions during the period 2000-2006 (Pradhan and Alakshendra, 2006). 
Moreover, the Prowess dataset used in this paper shows that within the manufacturing sector, 
pharmaceuticals is the top industry in terms of flows of outward FDI during the period 1999-
2007.5 Understanding the technological implications of foreign activities of Indian pharmaceutical 
firms is particularly interesting, as it has been observed that firms in this industry are investing 
abroad with the purpose of acquiring global capabilities to overcome their lack of cutting-edge 
technologies. This analysis is therefore illustrative, as it is now well documented that an increasing 
number of developing country firms have started to venture abroad with the purpose of acquiring 
foreign technologies to cope up with increasing global competition and stronger international 
property rights regimens (Athreye and Kapur, 2009).  
 
 As documented by Pradhan (2008), strategic government interventions facilitated the 
building of strong indigenous capabilities and conquest international markets via exporting in the 
pre-1990s period by Indian pharmaceutical firms. In particular, the soft patent policy that remained 
in place from the early 1970s until the mid-2000s allowed Indian pharmaceutical firms to patent 
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manufacturing processes instead of final products. By permitting the adaptation of imported 
technology and reverse engineering, this patent regime facilitated the development of local 
innovations, but was mainly based on cost-effective process rather than in the creation of new 
products.  However, with the migration to a stronger patent regime in 2005, as mandated by the 
WTO, Indian pharmaceutical firms have been observed to increasingly start investing in developed 
countries with the purpose of quickly acquiring new products and foreign knowledge, rather than 
using their limited resources in costly long-term innovations (Pradhan, 2008). 6 As such, it is 
expected that the overseas investments of Indian pharmaceutical firms may substitute domestic 
investments in technology.  
 
 However, on the other hand, it might be the case that a potential foreign market expansion 
induced by firms' overseas investments would encourage greater technological investments at 
home, as greater sales create more incentives to invest in costly technology. This potential channel 
for in-house technological improvements is tested in this paper by looking at the relevance of a 
firm's multinational (OFDI) status for the technology-exporting link.  In line with the insights 
from recent models of exporting and technology adoption, it is likely that the increase in exports 
that have accompanied the recent wave of overseas investments by Indian pharmaceutical 
companies might have provided them with a new impetus to upgrade their technological 
capabilities at home.   
 
 Controlling for unobserved firm heterogeneity and the endogeneity of the choice of 
foreign market participation, this paper shows that the export-intensity of Indian pharmaceutical 
multinationals is associated with higher rates of technology adoption. However, there is no 
evidence that the exports of non-multinational firms stimulate greater technology activity. These 
UHVXOWV KLJKOLJKW WKH LPSRUWDQFH RI WDNLQJ WKH LQWHUDFWLRQ EHWZHHQ H[SRUWLQJ DQG ILUP·V
multinational status into account. Another major finding is that OFDI appears to substitute 
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technology investments at home, suggesting that technology-seeking overseas investments tend to 
divert national resources from home to foreign countries rather than enriching domestic 
technological activities.    
 
The remainder of the paper is structured as follows. The next section presents the 
empirical approach. Section 3 describes the dataset.  Section 4 reports the main findings from the 
econometric estimations, and Section 5 concludes.   
 
2. Empirical approach   
 
This section describes the empirical approach used to identify the individual and combined 
effects of exporting and OFDI on the rate of technology adoption. The following non-linear 
panel data model of technology investment describes technology investment in the current 
period in terms of the SUHYLRXVSHULRG·VILUPFKDUDFWHULVWLFV 
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where i and t index firms and time periods respectively. The dependent variable is the amount of 
technology investment (I) normalised by total assets (K)7, fi denotes time-invariant firm-specific 
heterogeneity and His a random error term. In the above model EXP and OFDI capture the 
export intensity and the amount of OFDI respectively. The export intensity is also interacted with 
WKHILUP·VPXOWinational status (MNE) to allow for the fact that the investment-export nexus is 
likely to differ for multinational and non-multinational companies. 
Firm age captures learning-by-doing effects, whereas firm size reflects the extent to which 
economies of scDOH HQKDQFH ILUPV· DELOLW\ WR XQGHUWDNH SHUIRUPDQFH-enhancing investment. A 
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firm's internal liquidity is also likely to affect its ability to fund the cost of technological investments.  
To allow for this possibility the cashflow ratio is included as a measure of firm's internal liquidity. 
Another control variable is firm's productivity, which may impact technology investments in two 
opposing ways. On one hand, more productive firms may be more likely to afford investing in 
further productivity improvements (Bustos, 2011). On the other hand, least productive firms may 
investment more to catch-up with their competitors, which is consistent with the notion of firm 
level productivity-convergence (e.g.  Bernard and Jones, 1996).  
Finally, Equation 1 is estimated using a full vector of time dummies (Dt ) and a vector of two 
dummy variables (OWNi), which indicate whether the firm belongs to a business group and 
whether the firm is owned by the State, respectively. 
 
The treatment of the time-invariant unobserved heterogeneity, fi , and its relationship with 
the explanatory variables, constitutes an important concern when estimating equation 1.  In non-
linear panel data models with small time periods, it is not possible to treat the unobservables as 
fixed parameters to be estimated by standard maximum likelihood due to the incidental parameter 
problem.  In order to identify the partial effects of the explanatory variables, this paper adopts the 
Mundlak-Chamberlain approach by modelling the distribution of fi in a parametrical way. A 
common practice is to assume a linear relationship between fi and either the time means of the 
explanatory variables or a combinations of their lags and leads.  In terms of implementation this 
approach has the effect of adding firm-specific time averages (or a full set of leads and lags) of the 
regressors  to the set of explanatory variables in Equation 1 (Wooldridge, 2008, 2009).  
 
However, a potential problem with this approach is that it relies on the assumption of strict 
exogeneity of the explanatory variables conditional on the unobserved effects. But arguably, some 
explanatory variables in Equation 1 (i.e. productivity, size, liquidity, exporting and OFDI ) might 
be contemporaneously determined with, or even impacted by firms' technology investments. In 
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Equation 1 the covariates are lagged one period in order to minimize the potential problem of 
contemporaneous endogeneity. However, in order to better deal with potential endogenous 
explanatory variables, this paper uses a control function approach consisting of: 1) estimating a 
reduced form of each hypothesised endogenous variable on their lagged values and all other 
endogenous and exogenous regressors8; 2) obtaining the reduced residuals from these estimations; 
3) including these residuals in the list of covariates in Equation 1; and 4) performing the estimations 
using a pooled Tobit model with robust standard errors clustering at the firm level. The hypothesis 
of strict exogeneity is rejected if the coefficients on the residuals are significantly different from 
zero (Wooldridge, 2008).  
 
3. Database description  
 
This paper draws on the Prowess database compiled from audited company balance sheets and 
income statements by the Centre for Monitoring the Indian Economy. Prowess covers both 
publicly listed and unlisted firms from a wide cross-section of manufacturing, services, utilities, 
and financial industries. The companies covered by the database account for more than 70% of 
industrial output, 75% of corporate taxes and more than 95% of excise taxes collected by the 
Government of India. 
   
Table 1 gives the frequency distribution of the pharmaceutical firms in the sample by year 
and global status. Firms in Table 1 have been classified in five categories. The first category 
comprises those Indian firms that only serve the domestic market. The second group includes 
Indian firms that also export. The third category consists of those indigenous firms that export 
and invest abroad (Indian MNEs). The fourth group are those Indian MNEs that invest abroad 
but do not export, and the last category comprises all foreign firms operating in India. The category 
of foreign firms is dropped from the empirical analysis, since the main interest of this paper is to 
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examine whether exporting and investing abroad has encouraged technology upgrading by 
indigenous companies in India. It can be observed that the number of Indian pharmaceutical 
multinationals started to show a marked increase after 2000. This increase is largely due to 
significant improvements in the regulatory framework governing Indian outward investment. For 
example, since 2000 Indian companies have been allowed to make overseas investments by market 
purchases of foreign exchange without the approval of the Reserve Bank of India up to 400% of 
their net worth, compared to the previous limit of 50%.  It is also interesting to note that most 
Indian MNEs are engaged in exports. During the whole period, only a few pharmaceutical firms 
set up operations abroad without exporting.  Since the sample size is very small for this group of 
firms for all years, this category of firms is also dropped from the empirical analysis. 
 
[Table 1 about here] 
   The variables used in the regression analysis are defined in Table 1A in the appendix and 
their summary statistics are given in Table 2. Table 2 shows that about 59 percent of firms 
undertake technology investments and that, on average, these firms invest 4 percent of their total 
assets in technology. Table 2 also shows that, on average, more than 60% of pharmaceutical firms 
export and the fraction of output exported increased from 24% in the first half of the sample 
(1999-2002) to 28% in the second half.  The percentage of firms engaged in overseas investments 
and the amount of such investments also displayed significant increases between the two periods.  
 
[Table 2 about here] 
 
 Figures 2 depicts the share of firm-year observations and technology investment ordered 
by exporting and OFDI status. It is striking that although only 9.5% of pharmaceutical firms 
engaged in both exporting and OFDI, they enjoyed a disproportionately high share of the value 
technology investment, compare to the significantly larger fraction of firms that only export. This 
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appears to reinforce the idea that export-oriented Indian multinationals appear to be most willing 
to develop their technological capabilities. 
[Figures 2 about here] 
In order to isolate the causal effects of exporting and OFDI on the rate of technology 
adoption as well as to evaluate the interaction between them, it is important to control for a host 
of observable and unobservable firm characteristics. This is achieved within the non-linear panel 
data framework described in the previous section.  
 
4. Empirical findings 
 
Table 3 reports the marginal effects of exporting and OFDI on the expected amount of technology 
investments from pooled Tobit estimates. Full estimation results including all control variables are 
reported in Table 2A in the appendix. The marginal effects are calculated at the sample averages 
of the control variables and the standard errors are adjusted to allow for clustering at the firm level. 
In order to make this work comparable to previous related research, the first column of Table 3 
reports the individual effects of exporting and OFDI on firm's technology investments without 
accounting for firm heterogeneity. Similar to previous research examining the determinants of 
R&D in the context of India (Pradhan, 2002, 2009; 2010), the results show that firms' export 
intensity is positively associated with the pace of technology upgrading. However, in this 
specification the amount of overseas investments does not appear to have significant technological 
effects.  
 
[Table 3 about here] 
 To allow for the fact that the technology-exporting nexus is likely to differ for 
multinational and non-multinational companies, in column 2 of Table 3 the export intensity is 
LQWHUDFWHGZLWKWKHILUP·VPXOWLQDWLRQDO01(VWDtus. Interestingly, this exercise provides evidence 
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of heterogeneous technology-effects from exporting related WRILUP·VPXOWLQDWLRQDOVWDWXV:KLOH
the export intensity of non-multinationals does not appear to encourage technology investments, 
there is strong evidence of a positive relationship between the export intensity of Indian MNEs 
and their technology investment at home. The results show that a 1 percentage point increase in 
the export intensity of Indian MNEs results in a 0.013 percentage point increase in the intensity 
of domestic technology investments. This impact is economically important given that the average 
technology investment by Indian pharmaceutical firms (as a fraction of total assets) is 4.0 percent 
as reported in Table 2.  This finding is consistent with the notion of market-seeking exporting 
Indian MNEs being induced to invest in technology at home in order to become more competitive 
in international markets. The results in column 2 of Table 3 also uncover evidence of a substantial 
substitutive effect of firms' overseas investments on their rate of technology investments at home.  
The estimates show that all else constant a 1 percentage point increase in outward FDI reduces 
the amount of firms' technology investments by 0.011 percentage points.   
 
 The previous results do not account for potential unobserved firm heterogeneity.  
However, it is likely that firms' international activities in the form of exports and overseas 
investments are correlated with unobserved factors, such as managerial quality or risk behaviour, 
that also influence their technological decisions.  In column 3 of Table 3 firm's heterogeneity is 
accounted for by including the mean values of the covariates, as described in section 2.  The results 
confirm the previous findings, indicating that the exports of Indian multinational firms are a 
channel through which firm's multinational expansion enhances technology investments at home 
and that the higher the level of outward FDI, the lower the rate of domestic technology 
investments.9 
 
 As mentioned in Section 2, the above approach relies on the assumption of strict 
exogeneity once firm's unobserved heterogeneity is controlled for. However, this assumption 
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might be violated. For example, it might be plausible that a firm's technological effort might affect 
its export and/or outward FDI strategies.  To check whether the previous results are driven by 
the assumption of strict exogeneity conditional on firm's unobserved effects, column 4 of Table 3 
presents the results of using a control function approach, where the residuals from estimating a 
reduced form of each hypothesised endogenous variable are  included in the list of covariates.10  
As judged by the significance of the coefficients on the reduced residuals, it appears that firm's 
size, total factor productivity and outward FDI are likely to be endogenous (see column 4 of Table 
2A in the appendix). Interestingly, while the magnitude of the positive technological effects of the 
exports of Indian MNEs remains almost unchanged, the magnitude of the negative impact of 
overseas investments on firms· technological efforts increases significantly once firm's 
heterogeneity and the potential endogeneity of some regressors are accounted for. The estimate 
results show that a 1 percentage point increase in outward FDI reduces the amount of firms' 
technology by approximately 0.04 percentage points. This effect is almost 4 times higher than the 
effect presented in column 2.   
 
 The previous results are obtained using the whole unbalanced panel dataset of Indian 
pharmaceutical firms. Therefore, there is a potential risk that they might suffer from attrition bias.  
In order to check whether the results are robust to this potential problem, column 5 in Table 3 
reports the estimation results using only the subset of firms that are observed for all years. These 
estimates confirm that overseas investments and firms' technology investments at home are 
substitutive activities, with these negative effects being stronger in the balanced dataset. The results 
also confirm the positive effects of exporting amongst Indian MNEs.   
 
 So far, the combined effects between exporting and firms' multinational status have been 
accounted for by interacting the export intensity with a dummy variable for Indian MNEs (i.e. 
Indian firms with positive overseas investments).  This approach treats all Indian MNEs with large 
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and small overseas investments symmetrically.  However, in order to check whether the 
technology-exporting link of Indian MNEs varies with the amount of OFDI,  in column 6 of 
Table 3 the export intensity is interacted with 5 OFDI dummy variables, one for each quintile of 
the OFDI distribution. The results indicate that the positive technological enhancing effects from 
exporting are confined to Indian MNEs with low levels of overseas investments.  It might be 
plausible that only low levels of overseas investments are required to help firms to expand their 
exports, with the subsequent positive technological implications of such expansion. The results 
from this exercise show that, a 1 percentage point increase in the export intensity of Indian MNEs 
in the lowest two quintiles of the OFDI distribution increases the rate of technology investments 
by approximately 0.015.  These results became stronger when the dataset is reduced to a balanced 
panel as shown in column 7 of Table 3.  
       
 To check that the results presented in Table 3 are not inconsistent due to the imposed 
parametric specification of unobserved firm's heterogeneity (i.e. as a linear function of firm-
specific time average of the regressors), columns 1 to 4 in Table 4 report the estimated results 
obtained from modelling the distribution of unobserved heterogeneity as a linear function of all 
the leads and lags of the covariates instead of using their mean values. The main results from this 
exercise are in line with the previous results presented in Table 3.  
 
  In addition, in order to allow firm's heterogeneity to be correlated with the regressors in 
an unrestrictive way, columns 5 to 8 in Table 4 report the estimated results from a linear fixed 
effect model. As before, these results show that the exports of Indian multinationals exert a 
positive effect on the rate of technology investments at home, whereas the amount of overseas 
investments acts as a substitute for such investments.    
[Table 4 about here]  
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 Overall, the previous results highlight the importance of taking the interaction between 
exporting and multinational status into account and suggest that incurring the fixed cost of 
investing in technology is only attractive for exporting firms that have become multinationals in 
recent years, probably due to the larger sales in foreign markets that come with their overseas 
investments. The lack of evidence of technology enhancing effects from exporting amongst non-
multinational firms suggests that possibly these firms were induced to invest in technology in the 
past, when they started to export, but now, with less scope to improve foreign market access, they 
have less incentive to continue to upgrade their technological base. This is an interesting result, as 
the fundamental complementarity between exporting and investing abroad ²in particular, the 
increase in foreign market access that comes with overseas investments- has been absent from the 
existing work on trade and technology investments. 
 
Does the industry matter? 
So far the analysis has focused on the pharmaceutical industry. As argued in the introduction, there 
are good reasons for the choice of this industry, in particular its leadership in overseas investments 
by Indian manufacturing firms; as well as the well-documented behaviour of firms from this 
industry investing abroad with the purpose of acquiring global technologies to overcome their 
limited capabilities. Nonetheless, it is interesting to consider another equally important global 
oriented sector in India.  Within the service sector, the Indian software industry is the top industry 
in terms of Indian outward FDI. This industry offers an intriguing contrast to the pharmaceutical 
industry, not only for being predominantly service-based, but also because firms in this industry 
are considered to be technological leaders in a global scale. Therefore, the motivations behind their 
overseas investments are more for technological diversification rather than for technological 
acquisition (Pradhan, 2008).  As such, there is not so much scope for further domestic 
technological improvements in this industry. Estimation results using data from this industry show 
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no effects from exporting and/or outward FDI on firms' domestic technology investments.11  
These contrasting results highlight the importance of taking into account the sectoral heterogeneity 
of exporting and OFDI performance when evaluating the effects of globalization on firms' 
technological efforts. 
 
5. Conclusion 
 
Recent work in international economics has shown that improved access to foreign markets due 
to trade liberalization encourages firms to undertake complementary technology investments. 
Using firm-level data from the pharmaceutical industry in India, this paper contributes to this 
literature by examining whether the increase in foreign market access that comes with overseas 
investments also encourages indigenous firms to upgrade their technological capabilities at home. 
The analysis accounts for unobserved firm heterogeneity and the endogeneity of the choice of 
foreign market participation, and shows that the decision to invest abroad is crucial in determining 
the technology-exporting link. While there is evidence of technology-enhancing effects from 
exporting amongst Indian multinationals, this paper fails to find evidence that exporting non-
multinational firms invest more in technology than non-exporting ones. This finding is consistent 
with the notion of market-seeking exporting Indian multinationals being encouraged to invest in 
technology at home in order to take advantage of improved foreign market access and become 
more competitive abroad. Another striking result from this paper is the negative relationship 
between the level of overseas investment (OFDI) DQGILUPV·GRPHVWLFWHFKQRORJ\LQYHVWPHQWVD
result that is consistent with the notion of technology-seeking Indian multinational firms devoting 
their scarce resources to accessing existing technology abroad.     
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Overall, this study contributes to academic efforts that seek to pin down the channels 
WKURXJKZKLFKWKHFKRLFHRIIRUHLJQPDUNHWSDUWLFLSDWLRQVKDSHVILUPV·FRPSHWLWLYHDGYDQWDJHV,Q
particular, this paper informs existing economic theory by cautioning for the need to consider the 
heterogeneous nature of the exporting-technology investment link and take explicit account of the 
OFDI decision when examining this link.  
 
From a policy perspective, this paper shows that although outward FDI has a negative 
effect on firms' domestic technological efforts (a concern that has been raised amongst some 
academics and policy makers), the potential increase in exports induced by overseas investments 
creates an alternative opportunity for technological improvements at home. Policies aimed at 
promoting export-oriented OFDI can therefore be conducive for technological upgrading in the 
home economies. However, OFDI with the singular purpose of acquiring foreign technology 
might help the investing firms to overcome their lack of state-of-the art technology, but that would 
come at the cost of discouraging technology change in their home countries.  
 
Overall, conclusions regarding the role of outward FDI for technology enhancing 
investments should take into account the motivations behind such overseas investments.  In the 
case of Indian pharmaceutical firms it has been documented that outward FDI are mainly 
motivated by the desire to improve foreign market access (market-seeking motivation) and acquire 
foreign technology (technology-seeking motivation). As such, these effects are likely to operate in 
opposite directions.   
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Notes 
1
 See Melitz and Redding (2012) for a general description of the modelling techniques used in the international trade 
literature to capture the complementarities between exporting and investing in technology. 
2
 Other related papers examining the relationship between productivity, exporting and innovation more generally 
include Aw et al. (2007); Aw et al. (2011); Baldwin and Gu (2004); and Girma et al. (2008). In the case of India, early 
studies have found positive spillovers from exporting on R&D expenditures in the context of the liberalization reforms 
implemented during the 1990s (i.e. Kumar and Aggarwal, 2005 and Pradhan, 2002).    
3 See Amighni et al. (2015) for a recent literature review of academic work on emerging markets multinationals.    
4
 Data from the Directorate General of Commercial Intelligence and Statistics of the Indian Ministry of Commerce 
and Industry, available at: http://www.dgciskol.nic.in/ 
5
 Figure 1 shows the sectoral distribution of Indian manufacturing overseas investments in the Prowess database.   
6
 Pradhan (2008) shows that more than 80 percent of Indian pharmaceutical outward FDI during the period 2000-07 
was directed to developed countries, indicating a strong technology-seeking motivation behind such investments. 
7 Detail of the construction of the variables used in the empirical analysis is discussed in the next section and 
summarised in Table 1A in the Appendix. 
8
 Firms' age, group and state affiliation, and a set of time dummies are considered to be exogenous.   
9 The technology enhancing effects from exporting amongst Indian MNEs is also found by estimating Equation 1 
using a random effects Tobit model. However, a major disadvantage of this estimation technique is that it relies on 
the critical assumptions that the unobserved effects are uncorrelated with the explanatory variables and that, 
conditional on the regressors and unobserved heterogeneity, observations across time are independent. These 
assumptions are unlikely to hold.   
10 As mentioned in Section 2, firm's size, liquidity, productivity, exporting and investing abroad are suspected to be 
endogenous. The reduced form estimations for each of these hypothesised endogenous variables is carried out using 
pooled OLS. The results presented in column 4 of Table 3 are obtained by regressing each potential endogenous 
variable on their second and third lagged values and on a vector of exogenous regressors including firms' age, group 
affiliation, state ownership, and a set of time dummies. The choice of the control variables in these reduced form 
estimations was made by estimating an instrumental variables Tobit model using these variables as instruments and 
performing an Amemiya-Lee-Newey test for the validity of the instruments.  The main results are, however, robust to 
alternative specifications of the reduce form estimations. 
11 Results are available upon request.   
 
 
 
 
 
20 
 
 
References 
 
 
Amighni, A., Cozza, C., Giuliani, E., and Pavia, R., Scalera, V. (2015). Multinational enterprises 
from emerging economies: what theories suggest, what evidence shows. A literature review. 
Economia e Politica Industriale. 42 (3), 343-370. 
 
Athreye, S. and Kapur, S. (2009). The internationalization of Chinese and Indian firms: trends, 
motivations and strategy. Policy brief. 1. United Nations University, UNU-MERIT. 
 
Atkeson, A., and Burstein, A. T. (2010). Innovation, Firm Dynamics, and International Trade. 
Journal of Political Economy, 118, 433-84. 
 
Aw, B.Y, Roberts, M.J and Winston, T (2007)´ ([SRUW0DUNHW3DUWLFLSDWLRQ,QYHVWPHQWV in R&D 
and Worker Training, and the Evolution of )LUP3URGXFWLYLW\µThe World Economy, 14(1), 83²104. 
 
Aw, B.Y, Roberts, M.J and Xu, D. Y. (2011). R&D investment, exporting, and productivity 
dynamics, American Economic Review. 101,1312-1344. 
 
Baldwin, J.  R. and Gu, W. (2004). Trade liberalization: Export-market participation, productivity 
growth and innovation, Oxford Review of Economic Policy. 20, 372²392. 
 
Bernard, A.B. and Jones, C.I., (1996). Comparing apples to oranges: Productivity convergence and 
measurement across industries and countries, American Economic Review. 86, 1216²1238. 
 
Bustos, Paula (2011). Trade Liberalization, Exports, and Technology Upgrading: Evidence on the 
Impact of MERCOSUR on Argentinean Firms, American Economic Review. 101, 304-40. 
 
Chen, K. and Yang, S. (2013). Impact of outward foreign direct investment on domestic R&D 
activity: evidence from Taiwan's multinational enterprises in low-wage income. Asian Economic 
Journal 27 (1), 17-38.  
 
21 
 
 
Chuang, Y., and Lin, C. (1999). Foreign direct investment, R&D, and spillover efficiency: Evidence 
IURP7DLZDQ·VPDQXIDFWXULQJILUPVJournal of Development Studies 35 (4), 117²34. 
 
 
Constantini, J.A.  and Melitz, M.J. (2008). The Dynamics of Firm-Level Adjustment to Trade 
Liberalization, in Helpman, E., D. Marin  and T. Verdier Eds, The Organization of Firms in a Global 
Economy. Harvard University Press. 
 
Desai, M., Foley, F. Hines, J. (2005). Foreign direct investment and domestic economic activity. 
NBER Working Paper No. 11717.  
  
Girma, S., Görg. H. and Hanley, A. (2008). R&D and Exporting:  Comparison of British and Irish 
firms, Review of World Economics. 144, 750-773. 
 
Kumar, N. and Aggarwal, A. (2005). Liberalization, outward orientation and in-house R&D 
activity of multinational and local firms: A quantitative exploration for Indian manufacturing, 
Research Policy, 34, 441-460. 
 
Lileeva, A. and Trefler, D. (2010). Improved Access to Foreign Markets Raises Plant-Level 
3URGXFWLYLW\«)RU6RPH3ODQWVThe Quarterly Journal of Economics. 125, 1051-1099. 
 
Lin, H. and Yen, R. (2005). The interdependence between FDI and R&D: an application of 
endogenous switching model to Taiwan's electronic industry. Applied Economics. 37, 1789-99. 
 
Melitz, M. J. and Redding, S. (2012). Heterogeneous Firms and Trade. NBER Working Paper 18652. 
 
Pradhan, J. and Alakshendra, A. (2006). Overseas Acquisition versus Greenfield Foreign 
Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises? 
MPRA Paper No. 12339, available at http://mpra.ub.uni-muenchen.de/12339. 
 
3UDGKDQ-3¶/LEHUDOL]DWLRQILUPVL]HDQG5	'SHUIRUPDQFH$ILUPlevel study of Indian 
SKDUPDFHXWLFDOLQGXVWU\·Journal of Indian School of Political Economy 14 (4), 647-666. 
 
22 
 
 
Pradhan, J. (2008). Overcoming innovation limits through outward FDI: the overseas acquisition 
strategy of Indian pharmaceutical firms. Institute for Studies in Industrial Development. New 
Delhi.  
Pradhan, J. and Singh, N. (2009). Outward FDI and knowledge flows: a study of Indian automotive 
sector. International Journal of Institutions and Economics 1 (1), 156-187.  
 
Pradhan, J. (2010). R&D strategy of small and medium enterprises in India: trends and 
determinants. MPRA Paper No. 20951, available at https://mpra.ub.uni-
muenchen.de/20951/1/MPRA_paper_20951. 
 
Ramamurti, R. (2009). What have we learned about EMNEs? In Emerging Multinationals in Emerging 
Markets, Ramamurti, R. and Singh JV. (Eds), Cambridge University Press: Cambridge, UK, 
399-.426. 
 
Wooldridge, J (2008). Inference for partial effects in nonlinear panel-data models using Stata. 
Presentation at Summer 2008 North American Stata User's Group Meetings. Chicago.  
 
Wooldridge, J. (2009). Developments in Econometrics. Nonlinear Panel Data Models. Cemmap 
Lectures, UCL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
 
Figure 1: Sectoral distribution of overseas investments by Indian manufacturing firms, 
1999-2007 
 
6RXUFH$XWKRU·VDQDO\VLVEDVHGRQWKH3URZHVVGDWDVHW 
 
Figure 2: Distribution of firm-year observations and share of technology investment by 
global status  
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Table 1 
Frequency distribution of pharmaceutical firms by year and global status 
 
Year Domestic 
 
Exporter 
 
Exporter 
Indian  
MNE 
Non 
Exporter 
Indian  
MNE 
Foreign  
MNE 
Total 
1999 88 149 2 0 27 266  
2000 108 145 4 0 29 286  
2001 102 121 20 0 31 274  
2002 103 109 24 1 29 266  
2003 113 130 28 1 26 298  
2004 130 130 31 0 27 318  
2005 119 117 33 0 27 296  
2006 102 102 37 1 37 279  
2007 68 84 34 2 34 222  
Total 933 1,087 213 5 267 2,505 
                                6RXUFH$XWKRU·VDQDO\VLVEDVHGRQWKH3URZHVVGDWDVHW 
Table 2 
Summary statistics of main variables of interest: 
 
 1999-2002 2003-2007 
 mean Std dev. mean Std dev. 
Total technology investment (dummy) 0.58 0.49 0.59 0.49 
Total technology investment intensity (investors) 0.04 0.26 0.04 0.15 
Exports dummy 0.61 0.49 0.61 0.49 
Export intensity (exporters) 0.24 0.28 0.28 0.27 
OFDI dummy 0.05 0.21 0.14 0.34 
OFDI intensity (Indian MNEs) 0.06 0.13 0.12 0.25 
Size 3.33 1.56 3.30 1.99 
Total factor productivity (log) -4.66 1.29 -4.23 1.54 
Cash flow ratio 0.15 0.97 0.19 0.73 
Age 21.76 17.72 24.36 17.51 
        Note: see table 1A in the appendix for the exact definition of the variables. 
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Table 3:  Technology investment, exporting and OFDI 
Dependent variable: technology investment 
 Without controlling for 
firm's heterogeneity Accounting for firm's heterogeneity 
(Models with FDI-export interaction) 
Baseline 
Model 
(1) 
Model with 
FDI-
export 
interaction 
(2) 
(3) 
Accounting for potential endogeneity 
Unbalanced 
Panel (4) 
Balanced 
panel (5) 
Unbalanced 
Panel (6) 
Balanced 
panel (7) 
Exports 0.0054** 0.0036 0.0012 -0.0016 -0.0095 -0.0010 -0.0095 
 (0.0026) (0.0027) (0.0044) (0.0098) (0.0107) (0.0099) (0.0107) 
OFDI 0.0056 -0.0111* -0.0143** -0.0366*** -
0.0615*** 
-0.0161 -0.0403** 
 (0.0058) (0.0065) (0.0066) (0.0130) (0.0109) (0.0161) (0.0164) 
Exports*Indian MNEs  0.0134*** 0.0123** 0.0109** 0.0141*   
  (0.0050) (0.0052) (0.0054) (0.0079)   
Exports of Indian MNEs interacted with quintiles of OFDI 
Exports*Quintile 1      0.0152*** 0.0231*** 
      (0.0055) (0.0070) 
Exports*Quintile 2      0.0147* 0.0291** 
      (0.0083) (0.0129) 
Exports*Quintile 3      0.0059 -0.0002 
      (0.0094) (0.0083) 
Exports*Quintile 4      0.0046 0.0061 
      (0.0092) (0.0108) 
Exports*Quintile 5      -0.0108 -0.0092 
      (0.0087) (0.0115) 
Control variables yes yes yes yes yes yes yes 
Average values of the 
control variables 
no no yes yes yes yes yes 
Residual terms from 
reduced-form 
estimations of potential 
endogenous variables 
no no no yes yes yes yes 
Observations 1641 1641 1641 914 521 914 521 
Notes:  
a. All results based on a pooled Tobit model 
b. Marginal effects on the expected amount of technology investments are calculated at the sample means of the regressors.  
c. Standard errors (clustered at firm level) in parentheses 
d. *significant at 10%; ** significant at 5%; *** significant at 1% 
All specifications include the full set of time dummies. 
 
  
Table 4:  Technology investment, exporting and OFDI 
Dependent variable: technology investment 
Robustness checks 
 Modelling unobserved heterogeneity as a function of all 
the history of the covariates  
Allowing for unobserved heterogeneity to be correlated 
with the regressors in an unrestrictive way  
 Unbalanced 
panel (1) 
Balanced 
panel (2) 
Unbalanced 
panel (3) 
Balanced 
panel 
(4) 
Unbalanced 
panel 
(5) 
Balanced 
panel 
(6) 
Unbalanced 
panel 
(7) 
Balanced 
panel 
(8) 
Exports -0.0059 -0.0059 -0.0054 -0.0054 0.0040 0.0110 0.0045 0.0119 
 (0.0096) (0.0096) (0.0095) (0.0095) (0.0059) (0.0103) (0.0059) (0.0102) 
OFDI -0.0593*** -
0.0593*** 
-0.0536** -0.0536** -0.0372** -
0.0480*** 
-0.0023 -0.0081 
 (0.0143) (0.0143) (0.0216) (0.0216) (0.0166) (0.0173) (0.0222) (0.0271) 
Exports*Indian MNEs 0.0127* 0.0127*   0.0270*** 0.0320**   
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 (0.0071) (0.0071)   (0.0104) (0.0154)   
Exports of Indian MNEs by quintiles of overseas investments 
Exports*Quintile 1   0.0203*** 0.0203***   0.0334*** 0.0524*** 
   (0.0067) (0.0067)   (0.0106) (0.0181) 
Exports*Quintile 2   0.0065 0.0065   0.0485*** 0.0583*** 
   (0.0065) (0.0065)   (0.0150) (0.0145) 
Exports*Quintile 3   -0.0017 -0.0017   -0.0026 0.0010 
   (0.0078) (0.0078)   (0.0172) (0.0178) 
Exports*Quintile 4   0.0097 0.0097   0.0241 0.0287 
   (0.0091) (0.0091)   (0.0158) (0.0173) 
Exports*Quintile 5   0.0040 0.0040   -0.0051 -0.0069 
   (0.0128) (0.0128)   (0.0214) (0.0259) 
Residual terms from 
reduced-form 
estimations of potential 
endogenous variables 
yes yes yes yes no  no no 
Leads and lags of the 
regressors 
yes yes yes yes no no no no 
Obs 521 521 521 521 1641 689 1641 689 
a. All results in the first four columns are based on a pooled Tobit model. Marginal effects on the expected amount of technology 
investments are calculated at the sample means of the regressors. Note that modelling firm's heterogeneity as a linear function 
of all the leads and lags of the covariates forces the panel to be balanced. Hence, results in column 2 (4) are identical to those 
in column 1 (3). 
b. Results in the last fourth columns are obtained using a linear fixed effects model.  
c. Robust standard errors in parentheses 
d. *significant at 10%; ** significant at 5%; *** significant at 1% 
All specifications include the full set of time dummies. 
 
 
 
 
 
 
 
 
 
 
Appendix 
Table 1A 
Variable Definition 
Technology investment  The sum of real expenditures on own R&D, computers, software, royalty fees and imports of capital 
goods normalized by total assets  
Size Log of  total sales 
Total factor Productivity Log of total factor productivity estimated based on 3-input (labour cost, value of fixed capital and cost 
of intermediate material inputs) production function using the Levinshon-Petrin  (2003) technique 
which accounts for the endogeneity of inputs. 
Age Firm age since incorporation. 
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Exports  intensity Exports/total sales 
Cashflow ratio   Cash flow/tangible fixed assets 
Outward foreign direct investment (OFDI) 
Investment by Indian multinationals in their overseas subsidiaries normalized by total sales. 
,QGLJHQRXVILUPV·PXOWLQDWLRQDOVWDWXV
(MNE) 
Dummy variable equal to one if the Indian firm is engage in overseas investment, zero otherwise.  
 
 
 
Table 2A:  Technology investment, exporting and OFDI 
Dependent variable: technology investment 
 Without controlling for 
firm's heterogeneity Accounting for firm's heterogeneity 
(Models with FDI-export interaction) 
Baseline 
Model 
(1) 
Model with 
FDI-export 
interaction 
(2) 
(3) 
Accounting for potential endogeneity 
Unbalanced 
Panel (4) 
Balanced panel 
(5) 
Unbalanced 
Panel (6) 
Balanced panel 
(7) 
Size 0.0039*** 0.0037*** 0.0037** 0.0023 0.0003 0.0024 0.0004 
 (0.0006) (0.0006) (0.0015) (0.0022) (0.0029) (0.0022) (0.0029) 
Productivity -0.0006 -0.0003 0.0010 0.0017 0.0011 0.0013 0.0005 
 (0.0007) (0.0007) (0.0014) (0.0024) (0.0028) (0.0024) (0.0028) 
Cash flow ratio 0.0005 0.0006 0.0000 0.0002 -0.0026 -0.0000 -0.0023 
 (0.0008) (0.0008) (0.0008) (0.0036) (0.0041) (0.0035) (0.0040) 
Age 0.0001* 0.0001* -0.0010 0.0002 0.0000 0.0003 0.0000 
 (0.0001) (0.0001) (0.0008) (0.0011) (0.0001) (0.0011) (0.0001) 
Private group -0.0001 -0.0001 0.0000 0.0005 0.0012 0.0004 0.0011 
 (0.0018) (0.0017) (0.0018) (0.0022) (0.0029) (0.0023) (0.0029) 
State ownership -0.0119*** -0.0114*** -0.0114*** -0.0138*** -0.0191*** -0.0137*** -0.0189*** 
 (0.0041) (0.0041) (0.0042) (0.0048) (0.0040) (0.0048) (0.0039) 
Exports 0.0054** 0.0036 0.0012 -0.0016 -0.0095 -0.0010 -0.0095 
 (0.0026) (0.0027) (0.0044) (0.0098) (0.0107) (0.0099) (0.0107) 
OFDI 0.0056 -0.0111* -0.0143** -0.0366*** -0.0615*** -0.0161 -0.0403** 
 (0.0058) (0.0065) (0.0066) (0.0130) (0.0109) (0.0161) (0.0164) 
Exports*Indian 
MNEs 
 0.0134*** 0.0123** 0.0109** 0.0141*   
  (0.0050) (0.0052) (0.0054) (0.0079)   
 
Exports of Indian MNEs by quintiles of overseas investments 
 
Exports*Quintile 1      0.0152*** 0.0231*** 
      (0.0055) (0.0070) 
Exports*Quintile 2      0.0147* 0.0291** 
      (0.0083) (0.0129) 
Exports*Quintile 3      0.0059 -0.0002 
      (0.0094) (0.0083) 
Exports*Quintile 4      0.0046 0.0061 
      (0.0092) (0.0108) 
Exports*Quintile 5      -0.0108 -0.0092 
      (0.0087) (0.0115) 
 
Average values of the control variables 
 
Size   -0.0002 0.0016 0.0025 0.0015 0.0024 
   (0.0014) (0.0022) (0.0027) (0.0022) (0.0026) 
Productivity   -0.0016 -0.0025 -0.0037 -0.0020 -0.0031 
   (0.0014) (0.0022) (0.0028) (0.0022) (0.0028) 
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Cashflow ratio   0.0018 0.0012 0.0031 0.0011 0.0031 
   (0.0025) (0.0028) (0.0047) (0.0028) (0.0047) 
Age   0.0011 -0.0001 0.00001 -0.0002 0.00001 
   (0.0008) (0.0011) (0.0001) (0.0011) (0.0009) 
Exports   0.0028 0.0059 0.0123 0.0053 0.0120 
   (0.0057) (0.0106) (0.0137) (0.0107) (0.0136) 
OFDI   0.0085 0.0272 0.0563** 0.0478** 0.0772*** 
   (0.0148) (0.0209) (0.0225) (0.0222) (0.0235) 
 
Residual terms from reduced-form estimations of potential endogenous variables 
 
Size    0.0048** 0.0049** 0.0048** 0.0050** 
    (0.0023) (0.0020) (0.0023) (0.0020) 
Productivity    -0.0056*** -0.0046* -0.0055*** -0.0045* 
    (0.0021) (0.0025) (0.0020) (0.0024) 
Cashflow    -0.0006 0.0011 -0.0005 0.0008 
    (0.0033) (0.0040) (0.0033) (0.0039) 
Exports    -0.0034 0.0029 -0.0038 0.0030 
    (0.0076) (0.0087) (0.0077) (0.0088) 
OFDI    0.0268** 0.0451*** 0.0217* 0.0404*** 
    (0.0130) (0.0112) (0.0127) (0.0100) 
Observations 1641 1641 1641 914 521 914 521 
Notes:  
a. All results based on a pooled Tobit model  
b. Standard errors (clustered at firm level) in parentheses 
c. *significant at 10%; ** significant at 5%; *** significant at 1% 
All specifications include the full set of time dummies 
 
